<p>，/PRNewswire/ -- Schall 律师事务所是一家全国性的股东权益诉讼事务所，提醒投资者关于 Charming Medical Limited（“Charming” 或 “公司”）（NASDAQ: MCTA）提起的集体诉讼，因其违反了 1934 年证券交易法第§§10(b) 和 20(a) 及美国证券交易委员会制定的第 10b-5 条规则。</p>
<p>在 2025 年 10 月 21 日至 2025 年 11 月 12 日之间购买公司证券的投资者（“集体诉讼期间”）被鼓励在 2026 年 2 月 17 日之前联系该事务所。</p>
<p>如果您是遭受损失的股东，请点击此处参与。</p>
<p>我们还鼓励您联系 Schall 律师事务所的 Brian Schall，地址：2049 Century Park East, Suite 2460, Los Angeles, CA 90067，电话：310-301-3335，免费讨论您的权利。您也可以通过事务所的网站 www.schallfirm.com 或电子邮件 [email protected] 与我们联系。</p>
<p>本案的集体诉讼尚未获得认证，在认证之前，您并未由律师代表。如果您选择不采取任何行动，您可以保持缺席集体成员身份。</p>
<p>根据投诉，公司向市场发布了虚假和误导性声明。Charming 在 2025 年 11 月因其股票价格在没有任何公司新闻的情况下急剧上涨而受到 SEC 的交易暂停。该暂停是基于对公司股票涉及推广计划的指控，该计划涉及所谓的金融顾问在社交媒体和相关论坛上宣传公司。基于这些事实，公司在集体诉讼期间的公开声明是虚假且具有重大误导性的。当市场了解到 Charming 的真相时，投资者遭受了损失。</p>
<p>加入本案以追回您的损失</p>
<p>Schall 律师事务所代表全球投资者，专注于证券集体诉讼和股东权益诉讼。</p>
<p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
<p><strong>联系方式：</strong></p>
<p>Schall 律师事务所</p>
<p>Brian Schall，律师，</p>
<p>www.schallfirm.com</p>
<p>办公室：310-301-3335</p>
<p>[email protected]</p>
<p>来源：Schall 律师事务所</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAyJk5ld3NJdGVtSWQ9TEE3NjA3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDIwNDE5UFJfTkVXU19VU1BSX19fX19MQTc2MDc4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAyJk5ld3NJdGVtSWQ9TEE3NjA3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDIwNDE5UFJfTkVXU19VU1BSX19fX19MQTc2MDc4"/></p>

MCTA

标普全球医疗股指数 ETF - iShares

医疗业 ETF - SPDR

美国医疗保健供应商 ETF - iShares

医疗业 ETF - Vanguard

标普医疗保健服务 ETF - SPDR

<p>Schall 律师事务所提醒投资者，针对 Charming Medical Limited（纳斯达克代码：MCTA）提起的集体诉讼，指控其涉嫌证券欺诈。该诉讼声称在 2025 年 10 月 21 日至 2025 年 11 月 12 日的集体诉讼期间，公司发布了虚假声明，违反了《证券交易法》。遭受损失的投资者被鼓励在 2026 年 2 月 17 日之前联系该事务所，讨论他们的权利。该公司在 2025 年 11 月因涉嫌误导投资者的推广计划而面临美国证券交易委员会的交易暂停</p>

<p>, /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (&#34;Charming&#34; or &#34;the Company&#34;) (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Schall 律师事务所是一家全国性的股东权益诉讼事务所，提醒投资者关于 Charming Medical Limited（“Charming” 或 “公司”）（NASDAQ: MCTA）提起的集体诉讼，因其违反了 1934 年证券交易法第§§10(b) 和 20(a) 及美国证券交易委员会制定的第 10b-5 条规则。</p>
</div><p>Investors who purchased the Company's securities between October 21, 2025, and November 12, 2025, inclusive (the &#34;Class Period&#34;), are encouraged to contact the firm before February 17, 2026.</p>
<div class="lb-trans"><p>在 2025 年 10 月 21 日至 2025 年 11 月 12 日之间购买公司证券的投资者（“集体诉讼期间”）被鼓励在 2026 年 2 月 17 日之前联系该事务所。</p>
</div><p>If you are a shareholder who suffered a loss, click here to participate.</p>
<div class="lb-trans"><p>如果您是遭受损失的股东，请点击此处参与。</p>
</div><p>We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].</p>
<div class="lb-trans"><p>我们还鼓励您联系 Schall 律师事务所的 Brian Schall，地址：2049 Century Park East, Suite 2460, Los Angeles, CA 90067，电话：310-301-3335，免费讨论您的权利。您也可以通过事务所的网站 www.schallfirm.com 或电子邮件 [email protected] 与我们联系。</p>
</div><p>The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.</p>
<div class="lb-trans"><p>本案的集体诉讼尚未获得认证，在认证之前，您并未由律师代表。如果您选择不采取任何行动，您可以保持缺席集体成员身份。</p>
</div><p>According to the Complaint, the Company made false and misleading statements to the market. Charming was the subject of an SEC trading suspension in November 2025 after its shares spiked in price dramatically despite no news from the Company justifying its rapid increase. The suspension was based on allegations that the Company's shares were the subject of a promotion scheme involving supposed financial advisors touting the Company on social media and related forums. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Charming, investors suffered damages.</p>
<div class="lb-trans"><p>根据投诉，公司向市场发布了虚假和误导性声明。Charming 在 2025 年 11 月因其股票价格在没有任何公司新闻的情况下急剧上涨而受到 SEC 的交易暂停。该暂停是基于对公司股票涉及推广计划的指控，该计划涉及所谓的金融顾问在社交媒体和相关论坛上宣传公司。基于这些事实，公司在集体诉讼期间的公开声明是虚假且具有重大误导性的。当市场了解到 Charming 的真相时，投资者遭受了损失。</p>
</div><p>Join the case to recover your losses</p>
<div class="lb-trans"><p>加入本案以追回您的损失</p>
</div><p>The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.</p>
<div class="lb-trans"><p>Schall 律师事务所代表全球投资者，专注于证券集体诉讼和股东权益诉讼。</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.</p>
<div class="lb-trans"><p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>联系方式：</strong></p>
</div><p>The Schall Law Firm</p>
<div class="lb-trans"><p>Schall 律师事务所</p>
</div><p>Brian Schall, Esq.,</p>
<div class="lb-trans"><p>Brian Schall，律师，</p>
</div><p>www.schallfirm.com</p>
<div class="lb-trans"><p>www.schallfirm.com</p>
</div><p>Office: 310-301-3335</p>
<div class="lb-trans"><p>办公室：310-301-3335</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE The Schall Law Firm</p>
<div class="lb-trans"><p>来源：Schall 律师事务所</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjAyJk5ld3NJdGVtSWQ9TEE3NjA3OCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDIwNDE5UFJfTkVXU19VU1BSX19fX19MQTc2MDc4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA76078&amp;Transmission_Id=202602020419PR_NEWS_USPR_____LA76078&amp;DateId=20260202"/></p>

MCTA 的投资者有机会与 Schall 律师事务所合作，主导针对 Charming Medical Limited 的证券欺诈诉讼